This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

AsthmaSense Cloud Launches With New Features To Better Monitor Asthma

SEVERNA PARK, Md., April 11, 2013 /PRNewswire/ -- Medical technology company, iSonea Ltd. (ASX: ISN; OTCQX: ISOAY), launched Thursday the newest smartphone asthma management application, AsthmaSense™ Cloud, to help asthmatics adhere to physician-prescribed treatment plans.

(Photo: )

The AsthmaSense Cloud application, available on iPhone and Android platforms, has enhanced features to track and manage chronic asthma including:
  • Safe storage of a user's asthma profile and event history in a password-protected, HIPAA-compliant, cloud-based data warehouse;
  • Protected access and easy data recovery if one's phone is replaced, lost, stolen or damaged;
  • Ability to view and edit the application data on a computer;
  • Tracking system to identify potential risk patterns and trends in asthma symptoms, medication use and testing results;
  • Interactive medication and testing reminders as well as medication usage records;
  • One-touch dialing of contact numbers, including auto-selected emergency number based on GPS location; and
  • The ability to maintain multiple user profiles with a single application; a benefit to families with more than one person suffering from asthma. 

"Growing asthma trends represent a serious challenge in the United States and globally," said Michael J. Thomas, chief executive officer for iSonea. "The need for better, consumer-friendly asthma management tools is critical to improve the patient's well being while reducing costs.

"By improving awareness of symptoms, asthma episodes, medication usage and potential risks, AsthmaSense Cloud can help asthmatics adhere to a physician-prescribed treatment plan."

According to the Centers for Disease Control and Prevention, an estimated 25 million adults and children in the United States have asthma. It is estimated that asthma affects 300 million people globally, and an additional 100 million people will suffer from asthma by 2025 1. Increased emergency room visits, hospitalizations, medical costs and deaths reinforce the need for better monitoring.

The AsthmaSense smartphone application provides patients and caregivers with an easy-to-use monitoring tool that sends alerts and reminders to help manage the condition in accordance with a physician-prescribed treatment plan.  The addition of a convenient cloud portal increases the flexibility of storing, sharing and editing data.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,786.37 -12.12 -0.07%
S&P 500 2,088.59 -1.52 -0.07%
NASDAQ 5,119.2540 -8.2710 -0.16%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs